Canandaigua National Corp’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Buy
+10,827
New +$3.86M 0.34% 59
2022
Q4
$3.59M Buy
13,682
+754
+6% +$202K 0.61% 44
2022
Q3
$2.91M Buy
12,928
+646
+5% +$157K 0.52% 55
2022
Q2
$2.99M Sell
12,282
-289
-2% -$70.8K 0.53% 55
2022
Q1
$3.04M Buy
12,571
+1,824
+17% +$419K 0.46% 66
2021
Q4
$2.42M Buy
10,747
+226
+2% +$47.7K 0.36% 79
2021
Q3
$2.24M Sell
10,521
-220
-2% -$50.6K 0.36% 82
2021
Q2
$2.62M Buy
10,741
+187
+2% +$46K 0.42% 70
2021
Q1
$2.63M Sell
10,554
-2
-0% -$477 0.44% 68
2020
Q4
$2.43M Buy
10,556
+110
+1% +$25.4K 0.43% 77
2020
Q3
$2.65M Sell
10,446
-2,174
-17% -$539K 0.47% 64
2020
Q2
$2.98M Buy
+12,620
New +$2.88M 0.55% 54

Other funds holding AMGN

Canandaigua National Corp's AMGN Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Amgen (AMGN) in Q1 2026: 10,827 shares worth $3.81M. The stake represents 0.34% of the portfolio and ranks #59 among its holdings. This is a return to the name: Canandaigua National Corp previously reported a position in AMGN as recently as Q4 2022.

Canandaigua National Corp first reported a position in AMGN in Q2 2020 and has held it in 12 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Canandaigua National Corp held 10,827 shares of Amgen worth $3.81M as of Q1 2026.
  • Amgen was a new Canandaigua National Corp position in Q1 2026.
  • Amgen made up 0.34% of Canandaigua National Corp's portfolio in Q1 2026, its #59 holding.
  • Canandaigua National Corp first reported a position in Amgen in Q2 2020 and has held it in 12 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.